Despite an increasing trend in the incidence of breast cancer ( DeSantis et al., 2019 ), there has been a marked improvement in the prognosis of this disease, with the predicted 5-year survival rate increasing from 40% to approximately 90% over the past half century ( Siegel et al., 2021 ).
← all excerpts
PRR13 expression as a prognostic biomarker in breast cancer: correlations with immune infiltration and clinical outcomes.
1
—
—